AFG
KPRX icon

Albion Financial Group’s Kiora Pharmaceuticals KPRX Stock Holding History

Albion Financial Group’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$5 – 522
2024
Q1 		$5 Hold
1
– – ﹤0.01% 499
2023
Q4 		$4 Hold
1
– – ﹤0.01% 473
2023
Q3 		$4 Hold
1
– – ﹤0.01% 476
2023
Q2 		$4 Hold
1
– – ﹤0.01% 471
2023
Q1 		$21 Hold
1
– – ﹤0.01% 442
2022
Q4 		$21 Hold
1
– – ﹤0.01% 482
2022
Q3 		$0 Hold
1
– – ﹤0.01% 511
2022
Q2 		$0 Hold
1
– – ﹤0.01% 580
2022
Q1 		$0 Hold
1
– – ﹤0.01% 633
2021
Q4 		$0 Hold
1
– – ﹤0.01% 657
2021
Q3 		$1K Hold
1
– – ﹤0.01% 490
2021
Q2 		$1K Buy
+1
New +$1.55K ﹤0.01% 487
2020
Q4 		$1K Buy
+1
New +$1.38K ﹤0.01% 454

Other funds holding KPRX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Albion Financial Group's KPRX Position: Q2 2024 in Review

Albion Financial Group sold out of Kiora Pharmaceuticals (KPRX) in Q2 2024, closing a stake of 1 share — an estimated $5 sold.

Albion Financial Group first reported a position in KPRX in Q4 2020 and held it in 13 quarters. The position peaked at $1K in Q3 2021. 17 funds tracked by Wall St. Rank hold KPRX as of Q2 2024.

  • Albion Financial Group reported no remaining Kiora Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Albion Financial Group sold 1 Kiora Pharmaceuticals share in Q2 2024, an estimated $5.
  • Albion Financial Group first reported a position in Kiora Pharmaceuticals in Q4 2020 and held it in 13 quarters.
  • Albion Financial Group's Kiora Pharmaceuticals position peaked at $1K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2024.

Based on Albion Financial Group's 13F filing for Q2 2024, filed 10 Jul 2024.